Nevertheless, similar strategies used in treating cancer can be adopted for pain, such as developing new generations of EGFR inhibitors, employing different combinations of EGFR inhibitors, and/or combinations with non-EGFR inhibitors to develop non-opioid analgesics to treat oral cancer pain. The gene discussed is EGFR; the disease is lip and oral cavity carcinoma.